Phthalic Acid

Phthalic Acid

SCHEMBL3628215

C[C@H](O)c1ccccc1F.O=C(O)c1ccccc1C(=O)O

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 3/20 0.54
CES1 P23141 3/20 0.54
ALDH1A1 P00352 3/20 0.50
ALOX15 P16050 2/20 0.50
ALB P02768 1/20 0.47
KMT2A Q03164 2/20 0.45
MEN1 O00255 1/20 0.45
NOTUM Q6P988 1/20 0.44
MAPT P10636 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
CYP3A4 P08684 1/20 0.42
GAA P10253 4/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA4 P22748 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
AKR1C3 P42330 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phthalic Acid SCHEMBL3628213 1.00 CES2 (0.54) CES2CES1ALDH1A1ALOX15ALB
SCHEMBL213828 0.84 CES2 (0.48) CES2CES1ALDH1A1KMT2AMEN1
SCHEMBL29609066 0.84 CES2 (0.48) CES2CES1ALDH1A1KMT2AMEN1
SCHEMBL342468 0.84 CES2 (0.48) CES2CES1ALDH1A1KMT2AMEN1
SCHEMBL14088059 0.84 CES2 (0.48) CES2CES1ALDH1A1KMT2AMEN1
SCHEMBL625219 0.84 CES2 (0.48) CES2CES1ALDH1A1KMT2AMEN1
SCHEMBL2955775 0.83 ALDH1A1 (0.54) ALDH1A1ALOX15KMT2AMAPTHDAC8
SCHEMBL10971043 0.80 ALDH1A1 (0.52) ALDH1A1ALOX15KMT2AMAPTHDAC8
SCHEMBL3628328 0.79 ALDH1A1 (0.48) CES2CES1ALDH1A1ALOX15ALB
SCHEMBL3628211 0.79 ALDH1A1 (0.48) CES2CES1ALDH1A1ALOX15ALB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1935866-B1 PROCESS FOR PRODUCING OPTICALLY ACTIVE FLUOROBENZYL ALCOHOL CENTRAL GLASS CO LTD (JP) 2011-12-14 EP disclosed
US-7795478-B2 Process for producing optically active fluorobenzyl alcohol CENTRAL GLASS COMPANY, LIMITED (JP) 2010-09-14 US disclosed
US-20090240087-A1 Process for Producing Optically Active Fluorobenzyl Alcohol CENTRAL GLASS COMPANY, LIMITED (JP) 2009-09-24 US disclosed
EP-1935866-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE FLUOROBENZYL ALCOHOL Central Glass Company, Limited (JP) 2008-06-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090240087-A1 Process for Producing Optically Active Fluorobenzyl Alcohol ADH1A, ADH1C, ADH5 CES2 732/4885CES1 614/4885ALDH1A1 47/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.